Treg depletion studies in culture and in an orthotopic murine model of glioma suggested that the activity of the increased hematogenous populations of Tregs in GBM patients may be linked to Th2 responses and suppressed proliferation of CD4+ T cells [12]. The gene discussed is CD4; the disease is central nervous system cancer.